Since Roche was founded in 1896, we have been committed to innovation and to being at the forefront of medical discovery. Today, with a strong foundation of Roche scientists and technical capabilities, and a steadily expanding global research network, including alliances with many of the world's most respected research institutions and biotech companies, we are working to open up new horizons in healthcare. 

We invest nearly $3 billion a year in the discovery and development of new products and technologies in both diagnostics and pharmaceuticals. Our goal is to develop highly specific, clinically differentiated treatments. That search includes advances in determining disease predisposition and detection that will contribute to a comprehensive approach to healthcare delivery.